Dapitan, Jevon R.

HRN: 23-95-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
AMPICILLIN 1GM (VIAL)
10/26/2023
11/02/2023
IV
195mg
Q12
Neonatal Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: